Cargando…
Targeting the actin cytoskeleton: selective antitumor action via trapping PKCɛ
Targeting the actin cytoskeleton (CSK) of cancer cells offers a valuable strategy in cancer therapy. There are a number of natural compounds that interfere with the actin CSK, but the mode of their cytotoxic action and, moreover, their tumor-specific mechanisms are quite elusive. We used the myxobac...
Autores principales: | Foerster, F, Braig, S, Moser, C, Kubisch, R, Busse, J, Wagner, E, Schmoeckel, E, Mayr, D, Schmitt, S, Huettel, S, Zischka, H, Mueller, R, Vollmar, A M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4454332/ https://www.ncbi.nlm.nih.gov/pubmed/25165884 http://dx.doi.org/10.1038/cddis.2014.363 |
Ejemplares similares
Ejemplares similares
-
PKCɛ switches Aurora B specificity to exit the abscission checkpoint
por: Pike, Tanya, et al.
Publicado: (2016) -
The Actin Targeting Compound Chondramide Inhibits Breast Cancer Metastasis via Reduction of Cellular Contractility
por: Menhofer, Magdalena H., et al.
Publicado: (2014) -
Bryostatin Effects on Cognitive Function and PKCɛ in Alzheimer’s Disease Phase IIa and Expanded Access Trials
por: Nelson, Thomas J., et al.
Publicado: (2017) -
Targeting actin inhibits repair of doxorubicin-induced DNA damage: a novel therapeutic approach for combination therapy
por: Pfitzer, Lisa, et al.
Publicado: (2019) -
Localization Microscopy of Actin Cytoskeleton in Human Platelets
por: Mayr, Sandra, et al.
Publicado: (2018)